BluePath Solutions Acquires Qualia Bio, LLCJohnny Luong
BluePath’s initial acquisition expands its product and service offerings in the biopharmaceutical commercialization services sector.
BluePath Solutions, a Los Angeles based health economics and value communication consulting firm announced today that it has acquired Qualia Bio, LLC.
Qualia Bio is a specialty healthcare consulting firm with a focus on healthcare policy, market access, and reimbursement. Qualia Bio assists clients in the assessment and management of market access risk through a mix of data analytics, custom consulting research, and syndicated reports which deliver actionable insights to help biopharmaceutical manufacturers optimize product access.
BluePath provides market-leading solutions in the areas of value marketing & communications, health economic modeling, and health economics and outcomes research. The services and products provided by Qualia Bio are complementary to BluePath’s existing services and allow the firm to provide a more comprehensive set of offerings to further support its clients.
“We are pleased to welcome Qualia Bio to BluePath and look forward to the expanded expertise and enhanced capabilities this transaction brings to our clients” said Matthew Gitlin, PharmD, Founder and Managing Director of BluePath. Gitlin added, “Our newly combined firm will aid clients in effectively and efficiently communicating the unique value of their brands to healthcare decision makers and help patients gain access to innovative new therapies.”
For more information on Qualia Bio, please visit www.qualiabio.com.
BluePath Solutions is a consulting firm specializing in health economics and value communications. BluePath helps clients in the biopharmaceutical, medical device, and medical diagnostic space to attain, maximize, and retain the value of their healthcare technologies — not just at one static point in time, but across the entire lifecycle of the technology.
About Qualia Bio
Qualia Bio is a specialty healthcare consulting firm focused on healthcare policy, market access, and reimbursement issues as they relate to the biopharmaceutical industry.
Qualia helps their life science clients assess and manage market access risk through the use of quantitative and qualitative analytics. Their insights aid clients in anticipating and responding to emerging market developments and long-term industry trends.